Recurrent Basal Cell Carcinoma
Oncology·MeSH: Carcinoma, Basal Cell
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| patidegib | Sol-Gel Technologies Ltd. (SLGL) |
Frequently asked questions
How many drugs are in development for Recurrent Basal Cell Carcinoma?
BioSniper tracks 1 drug in development for Recurrent Basal Cell Carcinoma across 1 company.
How many clinical trials target Recurrent Basal Cell Carcinoma?
There are 1 clinical trial targeting Recurrent Basal Cell Carcinoma tracked by BioSniper.
Analyze Sol-Gel Technologies Ltd.'s Recurrent Basal Cell Carcinoma pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company